Administration, Oral
"Administration, Oral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The giving of drugs, chemicals, or other substances by mouth.
| Descriptor ID |
D000284
|
| MeSH Number(s) |
E02.319.267.100
|
| Concept/Terms |
Administration, Oral- Administration, Oral
- Drug Administration, Oral
- Oral Drug Administration
- Oral Administration
- Administrations, Oral
- Oral Administrations
- Administration, Oral Drug
- Administrations, Oral Drug
- Drug Administrations, Oral
- Oral Drug Administrations
|
Below are MeSH descriptors whose meaning is more general than "Administration, Oral".
Below are MeSH descriptors whose meaning is more specific than "Administration, Oral".
This graph shows the total number of publications written about "Administration, Oral" by people in this website by year, and whether "Administration, Oral" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 10 | 10 | | 1997 | 0 | 4 | 4 | | 1998 | 0 | 8 | 8 | | 1999 | 0 | 3 | 3 | | 2000 | 0 | 7 | 7 | | 2001 | 0 | 6 | 6 | | 2002 | 0 | 11 | 11 | | 2003 | 0 | 8 | 8 | | 2004 | 0 | 23 | 23 | | 2005 | 0 | 11 | 11 | | 2006 | 0 | 9 | 9 | | 2007 | 0 | 22 | 22 | | 2008 | 0 | 17 | 17 | | 2009 | 0 | 13 | 13 | | 2010 | 0 | 28 | 28 | | 2011 | 0 | 23 | 23 | | 2012 | 0 | 34 | 34 | | 2013 | 0 | 23 | 23 | | 2014 | 0 | 28 | 28 | | 2015 | 0 | 25 | 25 | | 2016 | 0 | 37 | 37 | | 2017 | 0 | 40 | 40 | | 2018 | 0 | 43 | 43 | | 2019 | 1 | 37 | 38 | | 2020 | 0 | 34 | 34 | | 2021 | 0 | 25 | 25 | | 2022 | 0 | 9 | 9 | | 2023 | 0 | 8 | 8 | | 2024 | 0 | 21 | 21 | | 2025 | 0 | 35 | 35 | | 2026 | 0 | 25 | 25 |
To return to the timeline, click here.
Below are the most recent publications written about "Administration, Oral" by people in Profiles.
-
Bodykevich EG, Castello Casta F, Flynn JK, Nichols CA, Nardone GA, Fennessey CM, Brooks K, Ruiz D, Simpson J, Vinton CL, Keele BF, Brenchley JM, Ortiz AM. Oral uracil treatment increases susceptibility to rectal SIV infection. PLoS Pathog. 2026 Oct; 22(10):e1014716.
-
Wood RA, Togias A, Burk CM, Sindher S, Dantzer JA, Sicherer S, Wang J, Shreffler W, Kim E, Keet C, Kulis M, Jones S, Scurlock A, Leung D, Lanser B, Bird JA, Parrish C, Vickery BP, Mudd K, Long A, Ezhuthachan I, Spergel J, Brown-Whitehorn T, Ligueros-Saylan M, Iqbal A, Cameron B, Huckabee CM, Yovetich N, Rogers N, Ozanne MV, Poyser J, Veri M, Hamrah SD, Lin AA, Wheatley LM, Chinthrajah RS. Treatment of Multifood Allergy With Omalizumab or Multiallergen Oral Immunotherapy: A Randomized Clinical Trial. JAMA Pediatr. 2026 Oct 01; 180(10):1067-1075.
-
Yu Y, Brooks KM, Doncel GF, Best BM, Marzinke MA, Mirochnick M, Anderson PL, Myer L, Celum C, Heffron R, Coleman J, Davey DLJ, Zhang L, von Kleist M, Hendrix CW, Momper JD, Bies R, Scott RK. Predicting Oral HIV Pre-Exposure Prophylaxis Efficacy in Cisgender Women Across Pregnancy and Postpartum. J Clin Pharmacol. 2026 Sep; 66(9):e70278.
-
Schacht JP, Sakai JT, Raymond K, Shelton R. Oral Semaglutide for Alcohol Use Disorder: A Randomized Clinical Trial. Am J Psychiatry. 2026 Sep 01; 183(9):636-645.
-
Wolinsky D, Srungaram D, Zhang A, Moore CF, Pierce-Messick ZJ, Zamarripa CA, Spindle TR, Strickland JC, Sempio C, Klawitter J, Campos Palomino J, Christians U, Feldner MT, Vandrey R, Bonn-Miller MO, Weerts EM, Bergeria CL. Safety, pharmacodynamics, and pharmacokinetics of oral cannabigerol in healthy adults. J Pharmacol Exp Ther. 2026 Aug; 393(8):104984.
-
Palmsten K, Seburg EA, Ziegenfuss JY, Vazquez-Benitez G, JaKa MM, Chambers CD, Avalos LA, Kharbanda EO. Provider Perspectives to Inform a Patient-Facing Decision Aid on Oral Corticosteroid Use During Pregnancy and Evaluation of the Aid. Pharmacoepidemiol Drug Saf. 2026 Jul; 35(7):e70413.
-
Savarirayan R, Hoover-Fong J, Irving M, Arundel P, de Bergua JM, Campeau PM, Candler T, Cocanougher BT, Cormier-Daire V, Edouard T, Fredwall SO, Harmatz P, Hoernschemeyer D, Irgens HU, Jamuar S, Kannu P, Legare JM, Leiva-Gea A, McDevitt H, Onesimo R, Phillips J, Del Pino M, Robinson ME, Rossi M, Skae M, Ward LM, White KK, Schmidt J, Lystig T, Salvatici A, Bai Y, Butler PW, van Veenhuyzen D, Rogoff D. Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia. N Engl J Med. 2026 Sep 03; 395(9):859-869.
-
Sempio C, Campos-Palomino J, Klawitter J, Peters EN, MacNair L, Haghdoost M, Bonn-Miller M, Harrison A, Babalonis S, Huestis MA, Christians U, Klawitter J. Metabolite patterns in human urine after oral administration of highly purified ?8-THCV. Forensic Toxicol. 2026 07; 44(2):437-444.
-
Venter C, Ryczaj K, Hicks AG, Mack DP, O'Mahony L, Smith PK, Brough HA. Nutritional, growth, and microbiome implications of oral immunotherapy: Unintended consequences and clinical considerations. Ann Allergy Asthma Immunol. 2026 Nov; 137(5):555-565.
-
Gouda P, Harrington J, Arps K, Sanders G, Chen A, Chiswell K, Hofmann P, Marsolo K, Asfaw K, Coppolecchia R, Alexander JH, Piccini J, Granger CB, May HT, Chrischilles E, Steinberg BA, Chamberlain AM, VanWormer J, Jones WS, Patel MR. Predictors of ischemic stroke and major bleeding among patients with atrial fibrillation in clinical practice. Am Heart J. 2026 Oct; 300:107490.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|